Search results
Myeloid sarcoma (MS), also known as chloroma (owing to its green color attributed to the enzyme myeloperoxidase), is a pathologic diagnosis for an extramedullary proliferation of blasts of one or more of the myeloid lineages that disrupt the normal architecture of the tissue in which it is found.
- Myeloid Sarcoma: Presentation, Diagnosis, and Treatment
Myeloid sarcoma is an extramedullary tumor of immature...
- Myeloid Sarcoma: Presentation, Diagnosis, and Treatment
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute myeloid leukemia (AML), although in some rare cases it may present in nonleukemic patients.
18 sie 2023 · Myeloid sarcoma (MS) is a very rare hematologic disorder. This study analyzes the early treatment options for patients with different types of MS and explores the prognostic factors of MS.
6 mar 2023 · Myeloid sarcoma (MS) is a rare and aggressive form of cancer that arises from immature myeloid hematopoietic cells that invade extramedullary tissues. It is most commonly seen in patients with acute myeloid leukemia (AML) and can also occur in transformed myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPN) [1].
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue architecture. It is a highly heterogenous condition that represents a variety of myeloid neoplasms.
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most cases concomitant with acute myeloid leukaemia (AML), rarely without bone marrow involvement.
2 lis 2023 · Background: Myeloid sarcoma (MS) is a distinct form of acute myeloid leukemia (AML) found in ~10% of patients, in which mass-forming myeloid blasts proliferate in extramedullary sites. MS may present as an isolated lesion as the primary manifestation of disease, co-occur with AML, or, more commonly, arise in the setting of AML relapse.
